450 Followers on Owler

Agena Bioscience, Inc.

Read more
Peter Dansky's photo - CEO of Agena Bioscience, Inc.

CEO

Peter Dansky

CEO Approval Rating

73/100

Founded:

2014

Status:

PrivateIndependent Company

AGENA BIOSCIENCE, INC. TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Peter Dansky

CEO

- -
189
$0
$3.5M
View Profile
1

Sean Emerson George

Co-Founder & CEO

86/100
788
$2.2B
$319M
View Profile
2

Rob Metcalf

CEO

66/100
20
$9.1M
$ < 1M
View Profile
3

CEO

- -
54
$13.1M
$17.4M
View Profile
4

Anne Wojcicki

Co-Founder & CEO

89/100
666
$1.5B
$243.9M
View Profile
5

CEO

- -
170
$19.9M
$17.7M
View Profile
6

Andrin Oswald

CEO

90/100
660
$84M
$220.6M
View Profile
7

David Jimenez

CEO

87/100
560
- -
$145.2M
View Profile
8

Jelena Aleksic

CEO

69/100
29
- -
$4.8M
View Profile
9

CEO

- -
50
- -
$12M
View Profile
10

James Weber

President

69/100
77
- -
$4.7M
View Profile

Missing a competitor? Contribute!

Invitae is one of Agena Bioscience, Inc.'s top competitors. Invitae was founded in 2010 in San Francisco, California. Like Agena Bioscience, Inc., Invitae also operates in the Biotechnology industry. Invitae generates $315.5M more revenue than Agena Bioscience, Inc..

NextGxDx is a top competitor of Agena Bioscience, Inc.. NextGxDx was founded in 2010, and is headquartered in Franklin, Tennessee. NextGxDx operates in the Business Support Services industry. NextGxDx generates $2.5M less revenue vs. Agena Bioscience, Inc..

Recombine is seen as one of Agena Bioscience, Inc.'s top competitors. Recombine is headquartered in New York, New York, and was founded in 2011. Like Agena Bioscience, Inc., Recombine also competes in the Biotechnology field. Recombine generates 495% the revenue of Agena Bioscience, Inc..

Agena Bioscience, Inc. Acquisitions

No recent acquisitions found related to Agena Bioscience, Inc.

Agena Bioscience, Inc. Funding History

No recent funding data found related to Agena Bioscience, Inc.

Agena Bioscience, Inc. Investments

No recent investments found related to Agena Bioscience, Inc.

Agena Bioscience, Inc. News

December 4, 2020Medical Buyer

Agena Bioscience launches MassARRAY

Agena Bioscience, a global provider of low-cost and high-throughput molecular testing solutions, toda... See more »
October 30, 2020Medical Buyer

Agena Bioscience gets EUA for MassARRAY SARS-CoV-2 panel

Agena Bioscience has secured the US Food and Drug Administration (FDA) Emergency Use Authorization (E... See more »
June 17, 2020Medical Buyer

Agena Bioscience Introduces iPLEX Pro SARS-CoV-2 Panel To Detect Covid-19

US-based life sciences and clinical diagnostics firm Agena Bioscience has launched the iPLEX Pro SARS... See more »
November 5, 2018Pharmabiz

Agena Bioscience introduces bone marrow engraftment assay for chimerism analysis

Agena Bioscience, a global provider of molecular testing solutions, has announced the release of the ... See more »

Agena Bioscience, Inc. Press Releases

September 29, 2017Business Wire

Focus on by Lung, Breast, Colorectal, Prostate and Others (Updated Report) - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. ... See more »
July 13, 2017EIN Presswire

AGENA BIOSCIENCE AND INTERMOUNTAIN HEALTHCARE ANNOUNCE RESEARCH COLLABORATION TO ADVANCE PRECISION MEDICINE

SALT LAKE CITY, UTAH, USA, July 14, 2017 /EINPresswire.com/ -- Agena Bioscience and Intermountain Hea... See more »
June 20, 2017PR Newswire

Agena Bioscience Announces Expanded Partnership with Assurex Health

SAN DIEGO, June 20, 2017 /PRNewswire/ -- Agena Bioscience today announced that Assurex Health, a whol... See more »
October 17, 2016Business Wire

Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic Markets 2016 including Screening Market with Potential Sizing Forecasts to 2020 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Circulating Tumor Ce... See more »
April 7, 2016Business Wire

AdnaGen, Biocept, Natera - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Liquid Biopsy Market... See more »
March 9, 2016Business Wire

Global Liquid Biopsy Market Opportunity & Technology Outlook 2020 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/q9g6km/glob... See more »

Agena Bioscience, Inc. Videos

Social Media

Agena Bioscience, Inc. Headquarters

4755 Eastgate Mall

San Diego, California92121

858-882-2800

Driving Directions »

Trending Companies

Agena Bioscience, Inc. Summary

ABOUT

Overview

Agena Bioscience operates as a life sciences and clinical diagnostics company that offers the MassARRAY system. Agena Bioscience, Inc. was founded in 2014. Agena Bioscience, Inc.'s headquarters is located in San Diego, California, USA 92121. Agena Bi...

CEO

Agena Bioscience, Inc.'s CEO, Peter Dansky, currently has an approval rating of 73%. Agena Bioscience, Inc.'s primary competitors are Invitae, NextGxDx & Recombine.

Frequently Asked Questions about Agena Bioscience, Inc.

  1. When was Agena Bioscience, Inc. founded?

    Agena Bioscience, Inc. was founded in 2014
  2. Who is Agena Bioscience, Inc.'s CEO?

    Agena Bioscience, Inc.'s CEO is Peter Dansky
  3. How much revenue does Agena Bioscience, Inc. generate?

    Agena Bioscience, Inc. generates $3.5M in revenue
  4. How much funding does Agena Bioscience, Inc. have?

    Agena Bioscience, Inc. has historically raised $0 in funding
  1. Where is Agena Bioscience, Inc.'s headquarters?

    Agena Bioscience, Inc.'s headquarters is in San Diego California, USA
  2. How many employees does Agena Bioscience, Inc. have?

    Agena Bioscience, Inc. has 189 employees
  3. What sector does Agena Bioscience, Inc. operate in?

    Agena Bioscience, Inc. is in Biotechnology, Medical Research & Laboratories
  4. Who are Agena Bioscience, Inc.'s competitors?

    Agena Bioscience, Inc.'s top competitors are Invitae, NextGxDx, Recombine